# Estrella Immunopharma, Inc.: filings

ESLA · Nasdaq · CIK 1844417 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/esla.md) · [Financials](/companies/esla/financials.md) · [Filings](/companies/esla/filings.md) · [Insiders](/companies/esla/insiders.md)

## Reports and events: 105 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 62, CORRESP 22, 3 17, UPLOAD 17, 424B3 16, 10-Q 15, 425 15, 4 14, S-1/A 13, SC 13G/A 9, S-4/A 7, SC 13G 6, EFFECT 5, 10-K 4, DEF 14A 3, NT 10-Q 3, S-1 3, SEC STAFF LETTER 3, 10-K/A 2, 8-K/A 2, DEFA14A 2, PRE 14A 2, PRER14A 2, 10-KT 1, 25-NSE 1, 424B4 1, 424B5 1, 8-A12B 1, CERT 1, S-3 1, S-4 1, S-8 1, SC 13D 1, SCHEDULE 13G 1, SCHEDULE 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 17:28 ET | [8-K](/filings/0001213900-26-113912.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-113912 |
| 2026-09-08 | 17:25 ET | [8-K](/filings/0001213900-26-098123.md) | 3.01 Delisting notice | 0001213900-26-098123 |
| 2026-08-21 | 17:00 ET | [8-K](/filings/0001213900-26-092657.md) | 3.01 Delisting notice | 0001213900-26-092657 |
| 2026-08-13 | 17:01 ET | [10-Q](/filings/0001213900-26-089215.md) | Quarterly report, period 2026-06-30 | 0001213900-26-089215 |
| 2026-06-30 | 17:29 ET | [8-K](/filings/0001213900-26-073847.md) | 5.07 Shareholder vote results | 0001213900-26-073847 |
| 2026-05-27 | 17:25 ET | [DEF 14A](/filings/0001140361-26-023012.md) | Proxy statement, period 2026-06-29 | 0001140361-26-023012 |
| 2026-05-18 | 21:26 ET | [10-Q](/filings/0001213900-26-058063.md) | Quarterly report, period 2026-03-31 | 0001213900-26-058063 |
| 2026-04-30 | 17:27 ET | [10-K/A](/filings/0001213900-26-050433.md) | Annual report, amended, period 2025-12-31 | 0001213900-26-050433 |
| 2026-03-18 | 20:53 ET | [10-K](/filings/0001213900-26-029357.md) | Annual report, period 2025-12-31 | 0001213900-26-029357 |
| 2026-01-22 | 20:51 ET | [S-1/A](/filings/0001213900-26-006410.md) | Registration statement, amended | 0001213900-26-006410 |
| 2026-01-16 | 17:08 ET | [S-1/A](/filings/0001213900-26-005233.md) | Registration statement, amended | 0001213900-26-005233 |
| 2026-01-13 | 17:21 ET | [8-K](/filings/0001213900-26-003998.md) | 3.01 Delisting notice | 0001213900-26-003998 |
| 2026-01-06 | 16:01 ET | [8-K](/filings/0001213900-26-001777.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-001777 |
| 2025-12-22 | 10:56 ET | [S-1](/filings/0001213900-25-124247.md) | Registration statement | 0001213900-25-124247 |
| 2025-12-04 | 09:21 ET | [8-K](/filings/0001213900-25-118097.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-118097 |
| 2025-11-12 | 16:08 ET | [10-Q](/filings/0001213900-25-109198.md) | Quarterly report, period 2025-09-30 | 0001213900-25-109198 |
| 2025-11-06 | 17:17 ET | [8-K](/filings/0001213900-25-107249.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-107249 |
| 2025-09-29 | 17:15 ET | [8-K](/filings/0001213900-25-093197.md) | 8.01 Other events | 0001213900-25-093197 |
| 2025-09-26 | 17:25 ET | [8-K](/filings/0001213900-25-092471.md) | 5.02 Departure or appointment of officers or directors | 0001213900-25-092471 |
| 2025-08-12 | 21:36 ET | [10-Q](/filings/0001213900-25-074567.md) | Quarterly report, period 2025-06-30 | 0001213900-25-074567 |
| 2025-08-07 | 20:32 ET | [8-K](/filings/0001213900-25-072746.md) | 3.01 Delisting notice | 0001213900-25-072746 |
| 2025-06-05 | 08:01 ET | [8-K](/filings/0001213900-25-051361.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-051361 |
| 2025-06-03 | 08:00 ET | [8-K](/filings/0001213900-25-050329.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-050329 |
| 2025-05-29 | 11:13 ET | [8-K](/filings/0001213900-25-048597.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-048597 |
| 2025-05-14 | 16:31 ET | [10-Q](/filings/0001213900-25-043365.md) | Quarterly report, period 2025-03-31 | 0001213900-25-043365 |
| 2025-05-02 | 17:00 ET | [8-K](/filings/0001213900-25-039261.md) | 3.01 Delisting notice | 0001213900-25-039261 |
| 2025-02-21 | 08:30 ET | [8-K](/filings/0001213900-25-015851.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-015851 |
| 2025-02-20 | 17:32 ET | [8-K](/filings/0001213900-25-015364.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-015364 |
| 2024-12-16 | 16:00 ET | [8-K](/filings/0001213900-24-109285.md) | 8.01 Other events | 0001213900-24-109285 |
| 2024-12-06 | 09:12 ET | [8-K](/filings/0001213900-24-106238.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-24-106238 |
| 2024-11-26 | 17:00 ET | [8-K](/filings/0001213900-24-102899.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-24-102899 |
| 2024-11-25 | 16:00 ET | [8-K](/filings/0001213900-24-102134.md) | 3.01 Delisting notice | 0001213900-24-102134 |
| 2024-11-14 | 16:15 ET | [10-Q](/filings/0001213900-24-098450.md) | Quarterly report, period 2024-09-30 | 0001213900-24-098450 |
| 2024-11-07 | 17:27 ET | [8-K/A](/filings/0001213900-24-095507.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-24-095507 |
| 2024-11-07 | 17:26 ET | [8-K](/filings/0001213900-24-095506.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-24-095506 |
| 2024-10-28 | 17:03 ET | [10-K/A](/filings/0001213900-24-091250.md) | Annual report, amended, period 2024-06-30 | 0001213900-24-091250 |
| 2024-09-27 | 19:50 ET | [10-K](/filings/0001213900-24-082374.md) | Annual report, period 2024-06-30 | 0001213900-24-082374 |
| 2024-08-20 | 17:00 ET | [8-K](/filings/0001213900-24-071174.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-071174 |
| 2024-08-06 | 18:17 ET | [8-K](/filings/0001213900-24-065292.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-065292 |
| 2024-07-02 | 19:48 ET | [8-K](/filings/0001213900-24-058085.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-058085 |
| 2024-05-15 | 21:49 ET | [10-Q](/filings/0001213900-24-043126.md) | Quarterly report, period 2024-03-31 | 0001213900-24-043126 |
| 2024-05-13 | 17:28 ET | [8-K](/filings/0001213900-24-042444.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-24-042444 |
| 2024-04-10 | 06:14 ET | [8-K](/filings/0001213900-24-031716.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-031716 |
| 2024-03-11 | 21:25 ET | [8-K](/filings/0001213900-24-021186.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-021186 |
| 2024-03-07 | 21:49 ET | [8-K](/filings/0001213900-24-020566.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-24-020566 |
| 2024-02-14 | 17:28 ET | [10-Q](/filings/0001213900-24-014191.md) | Quarterly report, period 2023-12-31 | 0001213900-24-014191 |
| 2024-02-02 | 08:30 ET | [8-K](/filings/0001213900-24-009325.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001213900-24-009325 |
| 2024-01-30 | 11:29 ET | [8-K](/filings/0001213900-24-007723.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-007723 |
| 2023-12-18 | 21:58 ET | [S-1/A](/filings/0001213900-23-096259.md) | Registration statement, amended | 0001213900-23-096259 |
| 2023-11-20 | 17:12 ET | [10-Q](/filings/0001213900-23-088827.md) | Quarterly report, period 2023-09-30 | 0001213900-23-088827 |

Page 1 of 3. [Older](/companies/esla/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 17:29 ET. No prices; not investment advice.